ROCKWELL MEDICAL, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount
ROCKWELL MEDICAL, INC. (RMTI) reported Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCreditsForeign · last filed 2025-03-20
- ROCKWELL MEDICAL, INC. effective income tax rate reconciliation, tax credit, foreign, amount for fiscal 2024 was $0.00.
- ROCKWELL MEDICAL, INC. effective income tax rate reconciliation, tax credit, foreign, amount for fiscal 2023 was $0.00.
- ROCKWELL MEDICAL, INC. effective income tax rate reconciliation, tax credit, foreign, amount for fiscal 2022 was $0.00.
- ROCKWELL MEDICAL, INC. effective income tax rate reconciliation, tax credit, foreign, amount for fiscal 2021 was $0.00.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-20 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-20 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-21 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 |
| 2020-12-31 | $0.00 10-K · filed 2022-04-08 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |